Entera Bio (ENTX) Other Working Capital Changes (2021 - 2026)
Entera Bio (ENTX) posted quarterly Other Working Capital Changes of $94000.0 for Q1 2026, down 71.77% year-on-year from $333000.0 in Q1 2025, and up 840.0% on a QoQ basis from $10000.0 in Q4 2025.
Entera Bio (ENTX) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported Other Working Capital Changes for 6 consecutive years, with $94000.0 the latest figure, recorded in Q1 2026.
- Quarterly Other Working Capital Changes rose 89.51% year-over-year to -$15000.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was -$15000.0 (up 89.51% YoY) and the FY2022 annual result came in at -$15000.0, up 89.51% from the prior year.
- Other Working Capital Changes retreated to -$15000.0 in Q1 2022 per ENTX's latest filing, from $15000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for ENTX reached as high as $15000.0 in Q4 2021 and fell as low as -$143000.0 in Q1 2021.
- A 5-year average of $18882.4 and a median of -$33000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes slumped 2966.67% — and 2025, when it soared 135.71%.
- Year by year, Other Working Capital Changes stood at $15000.0 in 2021, then tumbled by 200.0% to -$15000.0 in 2022.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$15000.0, $15000.0, and -$8000.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94,000.00 |
| Mar 31, 2026 | 94,000.00 |
| Mar 31, 2026 | 94,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Mar 31, 2025 | 333,000.00 |
| Mar 31, 2025 | 333,000.00 |
| Mar 31, 2025 | 333,000.00 |
| Dec 31, 2024 | -28,000.00 |
| Dec 31, 2024 | -28,000.00 |
| Dec 31, 2024 | -28,000.00 |
| Sep 30, 2024 | -190,000.00 |
| Sep 30, 2024 | -190,000.00 |